Ann: Notice of Annual General Meeting/Proxy Form, page-13

all I’m saying cap, imo a cap raise is a complete impossibility at the moment for loads of obv reasons.

no one disagrees with you about the board buying shares…

it is what it is….

there’s 2000 companies out there on the asx, Lbt probably had a hard enough time getting people on the board let alone ones that would buy shares…

it’s a red flag, of course, a risk of course, but what hasn’t been said about it already….

lack of fundamentals or whatever, the company has significant real world sales.

a break even target that is achievable (if thermo agreement as stated starts bearing fruit over the next 6months through next year as the 12-18 month sales cycle plays out)

and what’s looking like a seriously big deal in clean rooms developing.

early phase bio tech is obv speculation, but the probability of success has been increased with lbt’s real world sales.

the trick is just ignoring the share price for the mo

you’re not alone, and my guess is there will be a chance of people to get out if they want over the next few months at a significantly higher price than now

gltah

just my opinions